FAST NEWS: Drug companies say they’re unaffected by Silicon Valley Bank failure
The latest: Several Hong Kong-listed pharmaceutical companies disclosed that they have deposits at U.S.-based Silicon Valley Bank (SVB), which was taken over by the Federal Deposit Insurance Corp. (FDIC) last…
BGNE.US
6160.HK
CStone’s Commercialization Capacity Put to Test With Latest Drug Approval
Company’s four drug approvals in a year will contribute major revenue, but will also challenge CStone’s ability to commercialize its products Key takeaways: Its rollout of four new drugs will…
CStone Revs Up for Big Growth With New Drug Approval
Company says China has approved its latest cancer drug, which it is commercializing with global pharmaceutical giant Pfizer Key takeaways: CStone announced its monoclonal antibody drug Cejemly has been approved…
As U.S. Takes Aim at China Drug Makers, Innovators Appear at Biggest Risk
Washington’s campaign to keep cutting-edge technology out of China took a new twist late last week with the addition of Chinese medical companies to U.S. blacklists Key takeaways: Washington has…
CStone Finds Tonic in Steady Stream of Drug Approvals, Licensing Deals
Cancer drug specialist reported its first significant revenue in 2020, following a string of milestones capped by a $200 million investment from Pfizer Key takeaways: Strong upfront licensing fees helped…
